Genetic Analysis AS (XSAT:GEAN.TO.2) Operating Cash Flow per Share : kr0.00 (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Genetic Analysis AS Operating Cash Flow per Share?

Genetic Analysis AS's operating cash flow per share for the three months ended in Dec. 2023 was kr0.00. Genetic Analysis AS's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was kr0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -19.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Genetic Analysis AS's Operating Cash Flow per Share or its related term are showing as below:

XSAT:GEAN.TO.2' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -45.4 Med: -32.6 Max: -19.8
Current: -19.8

During the past 5 years, Genetic Analysis AS's highest 3-Year average Operating Cash Flow per Share Growth Rate was -19.80% per year. The lowest was -45.40% per year. And the median was -32.60% per year.

XSAT:GEAN.TO.2's 3-Year OCF Growth Rate is ranked worse than
76.11% of 180 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.5 vs XSAT:GEAN.TO.2: -19.80

Genetic Analysis AS Operating Cash Flow per Share Historical Data

The historical data trend for Genetic Analysis AS's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Analysis AS Operating Cash Flow per Share Chart

Genetic Analysis AS Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Genetic Analysis AS Quarterly Data
	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial										-	-	-	-	-

Competitive Comparison of Genetic Analysis AS's Operating Cash Flow per Share

For the Diagnostics & Research subindustry, Genetic Analysis AS's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genetic Analysis AS's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetic Analysis AS's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Genetic Analysis AS's Price-to-Operating-Cash-Flow falls into.

Genetic Analysis AS Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Genetic Analysis AS's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-17.233	/	0
	=

Genetic Analysis AS's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-3.742	/	0
	=

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00

Genetic Analysis AS Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Genetic Analysis AS's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Analysis AS (XSAT:GEAN.TO.2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Analysis AS (XSAT:GEAN.TO.2) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

GEAN:Sweden

Address

Kabelgata 8, Oslo, NOR, 0580

Website

https://www.genetic-analysis.com

Genetic Analysis AS is a research-driven diagnostic company dedicated to delivering innovative diagnostic solutions to the growing human microbiota market. It is providing a CE-marked gut microbiota analysis for testing bacterial imbalance in IBS and IBD patients.

Genetic Analysis AS (XSAT:GEAN.TO.2) Headlines

No Headlines